MARYLAND Baltimore
Johns Hopkins University School of Medicine,
Johns Hopkins Scleroderma Center, 5501 Hopkins Bayview
Circle, Baltimore, MD 21224.
Clinic Information:
Sees patients with systemic and localized forms of scleroderma,
raynauds, scleromyxedema, eosinophilic fasciitis and
scleroderma
Hours: Monday–Friday, 9 a.m.–4 p.m.
Appointments: Tyria Doggett or Brandy Miles at
410-550-7715, fax: 410-550-1363
Research Information:
Research coordinator: Cynthia Eberwein, 410-550-8582
Research interests: Raynaud’s Phenomenon,
Scleroderma Lung Disease, Autoimmunity, and Vascular
Disease
Web Site: http://scleroderma.jhmi.edu
| Studies |
Status |
| Role of T cells in Scleroderma Lung Disease (treatment
with Alefacept) |
Closed |
| Fasudil a rho-kinase inhibitor for the treatment
of Raynaud’s Phenomenon |
Call for status |
| Cohort Study to Determine Markers for the Development
of Severe Vascular Events in Scleroderma |
Call for status |
| RAPIDS 2 – Open Label study using bosentan
for digital ulcers in scleroderma |
Closed |
| Gleevec, a tyrosine kinase inhibitor for the treatment
of early active Scleroderma |
Call for status |
| Characterization of Raynaud’s Phenomenon
in an ambulatory setting (the ARM study) |
Call for status |
Physicians Affiliated with this Center:
- Fredrick Wigley, M.D., Director
- Laura Hummers, M.D., Co-Director
- Francesco Boin, M.D.
|
